# DIBBS #SPE2DP-27-T-0127

DLA request for 3 bottles of moxifloxacin hydrochloride tablets

**Posted:** October 20, 2026
**Respond By:** October 26, 2026
**Identifier:** SPE2DP-27-T-0127
**NAICS:** 424210

DLA Troop Support is seeking three bottles of moxifloxacin hydrochloride tablets for delivery to a U.S. Navy ship.
- **Government buyer:** Defense Logistics Agency (DLA), DLA Troop Support, Medical Supply Chain Pharm FSA.
- **Requested product:** 3 bottles of moxifloxacin hydrochloride tablets, 400 mg, with 30 tablets per bottle; NSN 6505-01-503-4772.
- **Approved manufacturers and source part numbers:**
  - **Rising Pharma Holdings, Inc.** — NDC57237-0156-30.
  - **Teva Pharmaceuticals USA, Inc.** — NDC00093-7387-56.
  - These are alternative approved sources for the same quantity, not separate quantities.
- **Delivery and handling:** FOB destination to USS Lewis B. Puller ESB 3; store at controlled room temperature and protect from high humidity.
- **Product requirement:** FDA-regulated drug with a 36-month, non-extendable shelf life.

### Description

MOXIFLOXACIN HYDROCHLO (QTY: 3, NSN: 6505-01-503-4772, Purchase Request: 7018767577)
  Approved Sources:
  - CAGE: 3V8D7, Part No: NDC00093-7387-56, Company: TEVA PHARMACEUTICALS USA, INC.
  - CAGE: 8FG82, Part No: NDC57237-0156-30, Company: RISING PHARMA HOLDINGS, INC.
 

[View original listing](https://www.dibbs.bsm.dla.mil/rfq/rfqrec.aspx?sn=SPE2DP27T0127)